We are creating a unified UKRI website that brings together the existing research council, Innovate UK and Research England websites.
If you would like to be involved in its development let us know.

Tackling antimicrobial resistance: behaviour within and beyond the healthcare setting

AHRC, along with the National Institute for Health Research (NIHR), the Medical Research Council (MRC), the Department for Environment, Food and Rural Affairs (Defra) and the Veterinary Medicines Directorate (VMD) are partnering in an ESRC-led funding initiative which invites applications for cross disciplinary proposals on the topic of behaviour relating to antimicrobial resistance (AMR).

This call takes place under a strand of the Cross-Council AMR initiative, details of which can be found on the MRC Funding pages

Antimicrobial resistance (AMR) is a term used to describe disease-causing organisms that have evolved to survive medicines that have been designed to kill them or stop their growth. While AMR is more often perceived as a biomedical or technical problem, the rise of AMR is considered to be largely a consequence of human action, and it is this aspect that forms the focus of this call.

The call aims to expand understanding of how the behaviour of public, professionals and organisations impacts on AMR: how it can enhance or control the spread of AMR; how it is affected by social, psychological and organisational context, cultures and history; and how it can be influenced to create different future scenarios.

AHRC is contributing up to £1m to the call which has potential for involvement of a number of AHRC disciplines, which might include, but is in no way limited to Anthropology, the Built Environment, Cultural Studies, Design, History (including Economic and Social History) Information Studies, Language, Law, Political History and Visual Representation.

Five sub themes have been identified in the following areas

  • Awareness and engagement
  • Public health as an opportunity to reduce the use of antibiotics: Preventing infection and transmission
  • Informal markets and access to antibiotics
  • Stewardship and appropriate use of antibiotics
  • Behaviour as it relates to animals and AMR

There will be two separate funding streams under this call:

  • Small scale pump priming grants - maximum of £250,000 at 100 per cent FEC for up to 24 months. These grants will be primarily for research relevant to the needs of Low and Middle Income Countries (LMICs)
  • Large scale collaborative grants - maximum of £2 million at 100 per cent FEC for up to 48 months. These grants will be open to proposals focusing on the UK or global settings